Evidence map›Paper›PMID 38951692›Full record

ArticleNature aging2024

Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice.

Sara Zumerle, Miles Sarill, Miriam Saponaro, Manuel Colucci, Liliana Contu, Edoardo Lazzarini, Roberta Sartori, Camilla Pezzini, Anna Rinaldi, Anna Scanu and 33 more

Abstract read
In one paragraph

Article in Nature aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Food science & nutrition · 2026
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

Sara Zumerle *Veneto Institute of Molecular Medicine, Padova, Italy.ORCID http://orcid.org/0000-0001-6980-0629
Miles Sarill *Veneto Institute of Molecular Medicine, Padova, Italy.ORCID http://orcid.org/0000-0002-0187-7299
Miriam SaponaroVeneto Institute of Molecular Medicine, Padova, Italy.
Manuel ColucciInstitute of Oncology Research (IOR), Bellinzona, Switzerland.ORCID http://orcid.org/0000-0002-4955-5416
Liliana ContuVeneto Institute of Molecular Medicine, Padova, Italy.
Edoardo LazzariniCardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Roberta SartoriVeneto Institute of Molecular Medicine, Padova, Italy.
Camilla PezziniVeneto Institute of Molecular Medicine, Padova, Italy.
Anna RinaldiDepartment of Medicine, Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Anna ScanuDepartment of Neuroscience, Rehabilitation Unit, University of Padova, Padova, Italy.
Jacopo SgrignaniInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Patrizia LocatelliInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Marianna SabbadinVeneto Institute of Molecular Medicine, Padova, Italy.
Aurora ValdataInstitute of Oncology Research (IOR), Bellinzona, Switzerland.
Daniela BrinaInstitute of Oncology Research (IOR), Bellinzona, Switzerland.
Isabella GiacominiVeneto Institute of Molecular Medicine, Padova, Italy.ORCID http://orcid.org/0000-0002-7154-7930
Beatrice RizzoVeneto Institute of Molecular Medicine, Padova, Italy.ORCID http://orcid.org/0000-0002-4243-4363
Alessandra PierantoniVeneto Institute of Molecular Medicine, Padova, Italy.
Saman SharifiVeneto Institute of Molecular Medicine, Padova, Italy.
Silvia BressanVeneto Institute of Molecular Medicine, Padova, Italy.
Claudia AltomareCardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Yulia GoshovskaCardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Chiara GiraudoDepartment of Medicine, University of Padova, Padova, Italy.
Roberto LuisettoDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Luca IaccarinoDepartment of Medicine, University of Padova, Padova, Italy.
Cristina TorcasioDepartment of Medicine, Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Simone MosoleInstitute of Oncology Research (IOR), Bellinzona, Switzerland.
Emiliano PasquiniInstitute of Oncology Research (IOR), Bellinzona, Switzerland.
Andrea RinaldiInstitute of Oncology Research (IOR), Bellinzona, Switzerland.
Laura PellegriniInstitute of Oncology Research (IOR), Bellinzona, Switzerland.ORCID http://orcid.org/0000-0002-8833-2987
Gregorio PeronDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-6007-6184
Matteo FassanDepartment of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0001-6515-5482
Stefano MasieroDepartment of Neuroscience, Rehabilitation Unit, University of Padova, Padova, Italy.
Andrea Maria GioriR&D Department, IBSA Farmaceutici Italia, Lodi, Italy.
Stefano Dall'AcquaDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Johan AuwerxLaboratory of Integrative Systems Physiology, Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Pietro CippàUniversità della Svizzera italiana, Lugano, Switzerland.
Andrea CavalliUniversità della Svizzera italiana, Lugano, Switzerland.
Marco BolisInstitute of Oncology Research (IOR), Bellinzona, Switzerland.ORCID http://orcid.org/0000-0003-4377-5079
Marco SandriVeneto Institute of Molecular Medicine, Padova, Italy.ORCID http://orcid.org/0000-0001-8509-7558
Lucio BarileCardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.ORCID http://orcid.org/0000-0002-5827-0439
Monica MontopoliVeneto Institute of Molecular Medicine, Padova, Italy. monica.montopoli@unipd.it.ORCID http://orcid.org/0000-0001-6182-4132
Andrea AlimontiVeneto Institute of Molecular Medicine, Padova, Italy. andrea.alimonti@ior.usi.ch.ORCID http://orcid.org/0000-0002-9362-2313

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating senescent cells within tissues contribute to the progression of aging and age-related diseases. Botanical extracts, rich in phytoconstituents, present a useful resource for discovering therapies that could target senescence and thus improve healthspan. Here, we show that daily oral administration of a standardized extract of Salvia haenkei (Haenkenium (HK)) extended lifespan and healthspan of naturally aged mice. HK treatment inhibited age-induced inflammation, fibrosis and senescence markers across several tissues, as well as increased muscle strength and fur thickness compared with age-matched controls. We also found that HK treatment reduced acutely induced senescence by the chemotherapeutic agent doxorubicin, using p16

Indexed as

Cellular SenescenceLongevityPlant ExtractsPolyphenolsAgingAnimalsCyclin-Dependent Kinase Inhibitor p16DoxorubicinLuteolinMaleMiceSalviaCyclin-Dependent Kinase Inhibitor p16DoxorubicinLuteolinPlant ExtractsPolyphenols

Identifiers

PMID38951692
PMCPMC11408255

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.